Impact of Metabolic Syndrome on Development of Contrast-Induced Nephropathy After Elective Percutaneous Coronary Intervention Among Nondiabetic Patients

Ozcan O. U., Er H. A., GÜLEÇ H. S., Ustun E. E., GEREDE ULUDAĞ D. M., Goksuluk H., ...More

CLINICAL CARDIOLOGY, vol.38, no.3, pp.150-156, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 38 Issue: 3
  • Publication Date: 2015
  • Doi Number: 10.1002/clc.22364
  • Journal Name: CLINICAL CARDIOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.150-156
  • Ankara University Affiliated: Yes

Abstract

BackgroundIdentifying patients who are vulnerable to development of contrast-induced nephropathy (CIN) is essential because of its association with prolonged hospitalization, increased cost, and increased in-hospital and long-term mortality rates.